Q. No.| 1. | Lipase | 2. | Protease |
| 3. | Streptokinase | 4. | Pectinase |
Name the blank spaces a, b, c and d given in the following table
|
Type of Microbe |
Scientific Name |
Commercial Product |
|
Bacterium |
A |
Clot buster enzyme |
|
B |
Aspergillus niger |
Citric acid |
|
Fungus |
Trichoderma polysporum |
C |
|
Bacterium |
D |
Butyric add |
| 1. | A – streptococcus, B – Fungus, C – Cyclosporin–A, D – Clostridium butylicum. |
| 2. | A – Clostridium butylicum, B – Streptococcus, C – Fungus, D – Cyclosporin –A |
| 3. | A – Cyclosporin –A, B – Clostridium butylicum, C – Streptococcus, D – Fungus |
| 4. | A – Fungus, B – Cyclosporin –A, C – Clostridium butylicum, D – Streptococcus. |
The fermentative activity of fungus Trichoderma polysporum yields which of the following substance?
| 1. | Statin | 2. | Cyclosporin - A |
| 3. | Gluconic acid | 4. | Soya sauce |
_______ enzyme is used to remove clots from the blood vessels of patients who have undergone _______leading to heart attack.
| 1. | A-Streptokinase; B-Myocardial infraction |
| 2. | A-Lipases; B-Arteriosclerosis |
| 3. | A-Proteases; B-Myocardial infraction |
| 4. | A-Pectinases; B-Atherosclerosis |
Eleven membered cyclic oligopeptides obtained from fungus Trichonderma polysporum and used as immunosuppressive agent is
| 1. | Statin | 2. | Streptokinase |
| 3. | Cyclosporin A | 4. | Proteases |
Which of the following is wrongly matched in the given table?
|
Microbe |
Product |
Application |
|
|
1. |
Clostridium butylicum |
Lipase |
removal of oil stains |
|
2. |
Trichoderma polysporum |
Cyclosporin A |
immunosuppressive drug |
|
3. |
Monascus purpureus |
Statins |
lowering of blood cholesterol |
|
4. |
Streptococcus |
Streptokinase |
removal of a clot from blood vessel |
| 1. | Saccharomyces cerevisiae |
| 2. | Trichoderma polysporum |
| 3. | Monascus purpureus |
| 4. | Aspergillus niger |
| Column I [Microbe] |
Column II [Role in human welfare] |
||
| A | Monascus purpureus | P | Swiss cheese production |
| B | Aspergillus niger | Q | Blood cholesterol lowering agent |
| C | Trichoderma polysporum | R | Commercial production of citric acid |
| D | Propionibacterium shermanii | S | Immunosuppressant |
Codes:
| A | B | C | D | |
| 1. | Q | R | P | S |
| 2. | R | Q | P | S |
| 3. | R | Q | S | P |
| 4. | Q | R | S | P |
Statins produced by the yeast Monascuspurpureus have been commercialized as:
| 1. | hormone replacement therapy for menopausal women. |
| 2. | increasing receptor sensitivity in type II diabetes mellitus. |
| 3. | a clotting factor for the treatment of Hemophilia A. |
| 4. | blood-cholesterol lowering agent. |
1. Sewage treatment
2. Nitrogen fixation
3. Biogas production
4. Fruit juice clarification and extraction
© 2026 GoodEd Technologies Pvt. Ltd.